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Summary: Eighty specimens from 20 patients with Dupuytren's disease and 7 biopsies of healthy palmar fascia
were analysed for their glycosaminoglycan isomer patterns with a combined enzymatic/HPLC method. The
diseased portions of palmar fascia tissue were characterized by elevated total glycosaminoglycans together
with a relative increase in the sulphated fractions. The macroscopic stages of nodules, bands and unaffected
tissue could be classified very well by multivariate statistical analysis on the basis of their glycosaminoglycan
patterns. The biochemical analysis provided evidence of the pathological process even in those specimens that
did not yet show any clinical symptoms of the disease.
Because of the role played by sulphated glycosami-
The mechanisms involved in the pathogenesis of Du- noglycans in the interaction with collagen (12), the
puytren's disease are still unknown (1). Recent studies question arises of whether there are changes in the
on the morphological changes in diseased tissue have proportions of glycosaminoglycans and their unsul-
demonstfated occlusioii of capillaries by cells that phated and sulphated isomers in affected palmar fas-
migrate into the perivascular space. These cells are cia that may have an influence on the collagen pattern
thought to be the origin of dedifferentiated cells that and the macromolecular structure. The present study
proliferate and metabolize in such Way that they cause was conducted to determine the types and amounts
contracture of the aponeurosis (2, 3). As to the pa- of the various sulphated and unsulphated glycosa-
thobiochemistry, an increase in collagen type III pro- minoglycans and to reassess the data published so far
tein has been reported (4-7), as has an increase in on the glycosaminoglycan content of both healthy
the proportion of chondroitin sulphate (4, 8 — 11). human palmar fascia and tissue from Dupuytren's
^ contracture, by employing a method of determination
') With support of the Deutsche Forschungsgemeinschaft (SFB more specific than any used previously. The new
54). method also enabled differentiation of the unsul-2) Present address: Institute for Clinical Chemistry and Labo- , , ~A . . - , n< e„i«i^t-/i ^mnr^ntc
ratory Medicine, university Hospital „BergmannsheiT Bo- Phated> C4-sulphated and C6-sulphated components
chum, FRG (11).
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Materials and Methods
Eighty biopsy specimens from 20 patients (aged 18 to 76 years;
2 women, 18 men) with Dupuytren's disease of the hand were
taken during surgery and classified according to their macro-
scopic appearance as
(1) apparently normal,
(2) tissue adjacent to bands or nodules,
(3) bands, or
(4) nodules.
For reference, palmar fascia from healthy persons was taken
during reconstruction surgery following accidental injury
(group Ο, η = 7, male) and during autopsies performed within
15 hours post mortem (n = 8, female). The specimens were
freed from adjacent tissue and blood and stored at — 20 °C
until processing. A representative sample of each specimen was
set aside for microscopic examination.
The total glycosaminoglycans were isolated and the various
fractions identified by specific enzymatic degradation, followed
by a quantitative determination of the respective disaccharide
metabolites by high performance liquid chromatography as
described elsewhere (11). This method is specific and reliable,
with an overall coefficient of variation of 6.8% at a substrate
concentration of 100 nmol per assay and a sensitivity of < 10
nmol per assay. Uronic acid was determined with the method
described by Bitter & Muir (13), hydroxyproline with that of
Stegemann (14) and DKA with that of Burton (15).
The microscopic examination of the specimens was performed
on samples taken from the tissue portions that were analysed
biochemically. Samples were stained with hematoxylin and by
the van Gieson technique. The classification was made according
to Millesi (16):
Stage 1A = thickening and stretching of fibres,
Stage IB = development of fibre bands,
Stage 2 = cell proliferation, and
Stage 3 = few cells only, unoriented thick fibre bundles (fig. 1).
A discriminant analysis according to Schneider (17) was per-
formed with the SPSS-X program "Discriminanf'-Release 2r.
Results
The results of the glycosaminoglycan determinations
on the normal palmar fascia tissue and the four
groups of diseased tissue are summarized in table 1
and figures 2 and 3. In the most advanced stage of
the disease the glycosaminoglycan content was double
that found in the unaffected palmar fascia. In the
early phases of the disease the hyaluronate content
remained almost constant, with a decrease in the later
stages, whereas the chondroitin sulphate and the der-
matan sulphate fractions increased with the severity
of the disease, being 10 times greater in nodules than
in healthy fascia. It should be noted that the autopsy
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Fig. 2. Glycosaminoglycan patterns of healthy palmar fascia and in specimens from Dupuytren's disease (bands, nodules).
Combined specific-enzymatic-HPLC analysis.
glycosaminoglycan content
hyaluronate content
total condroitin sulphate fraction
unsulphated, C4- and C6-sulphated isomers
total dermatan sulphate fraction
unsulphated, C4- and C6-sulphated isomers
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Fig. 3. Glycosaminoglycan patterns of healthy palmar fascia and in specimens from Dupuytren's disease (apparently normal
tissue, tissue adjacent to bands and nodules). Combined specific-enzymatic-HPLC analysis.
Explanation see figure 2. . f
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specimens of normal fascia contained smaller
amounts of glycosaminoglycans than the biopsy spec-
imens. The autopsy material proved to be unsuitable
for reference because of a post mortem drop in gly-
cosaminoglycans, mainly hyaluronate (tab. 2). How-
ever, both collagen and DNA contents remained un-
changed in the autopsy specimens, compared with the
biopsy material. The chondroitin sulphate isomer pat-
tern found in Dupuytren's contracture tissue was char-
acterized by a very marked increase in unsulphated
chondroitin, which was 500 times higher than in
healthy fascia (fig. 2). The main portion of the chon-
droitin sulphate fraction was the 6-sulphated com-
ponent, which showed a concentration 10 times higher
than in healthy fascia. However, in the dermatan
sulphate fraction the elevation in diseased palmar
fascia was due entirely to the 4-sulphated compound,
which is the predominant isomer in the healthy palmar
fascia (fig. 2). Regarding the unsulphated and 6-sul-
phated compounds, it must be kept in mind that the
concentrations of these substances in palmar fascia
are at the lower limit of the range of measurement of
the method applied. Therefore, no conclusive state-
ment can be made as to whether changes in the
dermatan sulphate isomer pattern occur during the
course of the disease (fig. 2).
Although less pronounced, the changes in the glycos-
aminoglycan patterns in tissue adjacent to nodules
-6 - 4 - 2 0 2 4
Canonical discriminant function 1
Fig. 4. Classification of specimens from healthy palmar fascia
and Dupuytrerfs disease by multivariate statistical eval-
uation (18) of the glycosaminoglycan patterns: 9 vari-
ables (hyaluronate, total chondroitin sulphate, total der-
matan sulphate, and the respective unsulphated, C4-
and Co^sulphated isomers).
• healthy control
• apparent normal fascia
A fascia adjacent to sträng and nodules
• sträng
• nodules
The open symbols indicate the respective group cen-
troid.
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Tab. 3. Clinical, historaorphological and biochemical classification of 46 specimens from Dupuytren's disease. Clinical classification
according to the macroscopic appearance of the specimen. Microscopic staging according to Millesi (16). Biochemical
classification by multivariate statistical analysis (17) of the glycosaminoglycan patterns. Each number in the morphologic
stage areas represents one classified specimen. Its size expresses the respective biochemical classification (stage 0: healthy
palmar fascia, diseased fascia stages 1 through 4).
Microscopic staging
1 A l B
Clinical classification
Group 1
Apparently normal
Group 2
Tissue adjacent to bands and nodules
Group 3
Bands
Group 4
Nodules
1 1
2 2 2 2 2 2 2 2
1
2
0
1 1 1
2 2 2 2
3 3 3 3 3 3 3 3 3 3 3 3 3
2 2
4 4 4 4 4 4 4
Tab. 4. Classification of results of specimens from healthy palmar fascia and Dupuytrerfs disease by multivariate statistical
analysis (18) on the basis of 9 variables of biochemical parameters (see fig. 3). Definitions of groups predicted according
to the macroscopic appearance of the specimens.
Classification of results
Actual group No. of Predicted group membership
cases
Group 0 1 4
Healthy controls
Group 1 2 12
Apparently normal fascia
Group 2 3 20
Adjacent fascia
Group 3 4 19
Band
Group 4 5 1 1
Nodules
Percent of "Grouped" cases correctly classified:
1
4
100.0%
0
0.0%
1
5.0%
0
0.0%
0
0.0%
81.82%
2
0
0.0%
8
66.7%
4
20.0%
0
0.0%
0
0.0%
3
0
0.0%
3f25.0%
15
75.0%
0
0.0%
0
0.0%
4
0
0.0%
1
83%
0
0.0%
18
94.7%
2
73.2%
5
0
0.0%
0
0.0%
0
0.0%
1
5.3%
9
81.8%
and bands as well as in apparently healthy portions
of diseased palmar fascia were still great enough to
classify these tissue as clearly diseased (fig. 3, tab. 1).
These findings are compatible with the elevation in
DNA and*in hydroxyproline concentrations (tab. 1)
as well as with the increase in the number of cells (2,
18) reported for these specimens of diseased palmar
fascia.
A multivariate statistical analysis (17) of the data
yielded a classification that clearly distinguished be-
tween the specimens taken from nodules or bands and
those from apparently normal or adjacent tissue, or
from the healthy reference specimens (fig. 4, tab. 3).
This biochemical classification was thus im good
agreement with the macroscopic classification. A less
satisfactory agreement, however, was found with the
results of the microscopic examinatior>sf(tab. 4).
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Discussion
Data on the total glycosaminoglycan content, as well
as on the distribution pattern of their fractions of
palmar fascia from healthy subjects and from individ-
uals with Dupuytren's contracture are sparse and for
methodological reasons of limited value. Using elec-
trophoresis for differentiation of the glycosaniino-
glycans, Flint and coworkers (8) showed that the
elevation of the total glycosaminoglycans seen in Du-
puytren's tissue is based mainly on the increase in the
chondroitin sulphate fraction. The findings in the
present study are in general agreement with the ob-
servations of Flint et al., although no detailed com-
parisons can be made because the Flint findings are
based on relative concentrations of glycosaminogly-
cans and the use of autopsy specimens for reference.
In contrast, our data were obtained by specific en-
zymatic degradation of the glycosaminoglycans and
quantitative determination of the respective disac-
charide metabolites by high performance liquid chro-
matography. The specificity, sensitivity, and reliability
of this procedure allow quantitative analyses on very
small specimens from various parts of the afflicted
palmar fascia and differentiation between the sul-
phated and unsulphated isomers of the individual
glycosaminoglycans. The glycosaminoglycan isomer
pattern found in the Dupuytren's contracture tissue
showed an increase in the 6-sulphated compounds,
and thus a change in the ratio of the 4- to the 6-
sulphates (fig. 2). With regard to the high synthesis
rate of chondroitin-6-sulphate, it seems likely that the
concentration of the unsulphated precursors should
also increase. The overall ratio of unsulphated to
sulphated glycosaminoglycans shifts toward the sul-
phated compounds because of the decrease in the
hyaluronate concentration and the increase in both
chondroitin and dermatan sulphate as the disease
progresses. Mori & Honda (12) presented experimen-
tal evidence for the functional importance of the pro^
teoglycan sulphate groups iri fibrillogenesis in heart
valve fascia. These findings support the hypothesis
that changes in the relation of sulphated to unsul-
phated glycosaminoglycans in Dupuytren's contrac-
ture give rise to aberrations in the structure of fibre
proteins and the subsequent contracture. The bio-
chemical changes found in the glycosaminoglycans
allowed staging of the disease in which stages 3 (band)
and 4 (nodules) could be clearly identified, but stages
1 (apparently normal) and 2 (adjacent tissue) could
iiot be separated from each other or from healthy
palmar fascia. However, the biochemical changes in
stages 1 and 2 did provide clear evidence of the onset
of the pathological process in these portions of tissue
that appeared to be unaffected when examined ma-
croscopically. The same was true for the microscopic
examination of both stage 1 and stage 2 specimens,
although the staging of a given specimen was some-
times different from the macroscopic and/or biochem-
ical classification (tab. 4). This difference resulted
from the morphological inhomogeneity of the dis-
eased tissue and the consequent effect of sample se-
lection on the classification. In contrast, the biochem-
ical analysis provided a finding that was valid for the
whole specimen. In clinically and macroscopically un-
suspicious palmar fascia (stage 1 in the present study)
Kischer & Speer (2) and Mohr & Vossbeck (18) dem-
onstrated, by electron microscopy and autoradiogra-
phy respectively, a proliferation of endothelial cells in
capillaries, migration of these cells and perivascular
accumulation. Kischer & Speer (2) term this early
stage of the disease "pre-Dupuytren", which may cor-
relate with our biochemically defined stage 1 (appar-
ently normal). Cell culture experiments with cell lines
derived from cells isolated from Dupuytren's contrac-
ture specimens showed an abnormal capacity to syn-
thesise sulphated glycosaminoglycans and collagen,
which the authors attribute to a permanent modula-
tion of metabolic cell characteristics, which can be
propagated in cell culture (19). In addition to the
dedifferentiation of palmar fascia cells or cells of other
origin,· continuous stimulation of the fascia cells by
abnormal matrix components or exogenous sub-
stances such as growth factors may also induce and
maintain metabolic malfunctions.
In conclusion, glycosaminoglycan analysis with the
combined enzymatic/HPLC method used in the pres-
ent study allows characterization and classification of
biopsy specimens from Dupnytren's contracture. The
typical changes in the isomer fractions suggest meta-
bolic aberrations in cells of so far unknown origin
and dedifferentiation. Malcomposition of the extra-
cellular matrix carbohydrates suggests that these car-
bohydrates may interact with the cell surface, thereby
inducing and maintaining aberrations of metabolism
and proliferation of the cells. The interactions between
fibre proteins and proteoglycans are probably dis-
turbed, with subsequent development of the contrac-
ture. Regarding the latter process, a study on the role
of proteoglycans in the pathogenesis of the contrac-
ture is in progress.
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